Modification of cardiac disease by histone deacetylase 6 in pressure-overloaded hypertrophy

被引：0
|
作者：
Sanbe, A. [1 ]
Matsushita, N. [1 ]
Aoyagi, T. [1 ]
Takahashi, N. [1 ]
Tezuka, Y. [1 ]
Nishigori, H. [1 ]
Hirose, M. [1 ]
机构：
[1] Iwate Med Univ, Iwate, Yahabacho, Japan
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5590
引用
收藏
页码：1009 / 1009
页数：1
相关论文
共 50 条
  • [1] Is cardiac hypertrophy a required compensatory mechanism in pressure-overloaded heart?
    Samuel, Jane-Lise
    Swynghedauw, Bernard
    JOURNAL OF HYPERTENSION, 2008, 26 (05) : 857 - 858
  • [2] Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice
    Ogita, H
    Node, K
    Liao, YL
    Ishikura, F
    Beppu, S
    Asanuma, H
    Sanada, S
    Takashima, S
    Minamino, T
    Hori, M
    Kitakaze, M
    HYPERTENSION, 2004, 43 (02) : 237 - 242
  • [3] Modification of cardiac disease by transgenically altered histone deacetylase 6
    Sanbe, Atsushi
    Inomata, Yui
    Matsushita, Naoko
    Sawa, Yohei
    Hino, Chizuru
    Yamazaki, Hinano
    Takanohashi, Kei
    Takahashi, Natsuko
    Higashio, Rieko
    Tsumura, Hideki
    Aoyagi, Toshinori
    Hirose, Masamichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 631 : 48 - 54
  • [4] EFFECTS OF CORONARY VASCULAR MEDIAL HYPERTROPHY ON DECREASED CORONARY PERFUSION IN PRESSURE-OVERLOADED CARDIAC-HYPERTROPHY
    ITO, N
    ISOYAMA, S
    KUROHA, M
    TAKISHIMA, T
    CLINICAL RESEARCH, 1990, 38 (02): : A331 - A331
  • [5] Osteoglycin regulates cardiac fibrosis in the pressure-overloaded heart
    Deckx, S.
    Van Aelst, L.
    Carai, P.
    Papageorgiou, A.
    Heymans, S.
    CARDIOVASCULAR RESEARCH, 2014, 103
  • [6] Sodium myo-inositol cotransporter 1 affects cardiac hypertrophy in pressure-overloaded mouse hearts
    Marino, A.
    Cumps, J.
    Guilbert, L.
    Ginion, A.
    Bertrand, L.
    Horman, S.
    Beauloye, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 18 - 19
  • [7] COLLAGEN DEPOSITION DETERMINES THE REVERSIBILITY OF DECREASED CORONARY VASODILATOR CAPACITY IN PRESSURE-OVERLOADED CARDIAC-HYPERTROPHY
    ISOYAMA, S
    SATO, F
    TAKISHIMA, T
    CLINICAL RESEARCH, 1991, 39 (02): : A231 - A231
  • [8] #Sodium myo-inositol cotransporter 1 affects cardiac hypertrophy in pressure-overloaded mouse hearts
    Marino, Alice
    Cumps, Julien
    Ferte, Laura
    Bertrand, Luc
    Horman, Sandrine
    Beauloye, Christophe
    ACTA CARDIOLOGICA, 2023, 78 : 5 - 5
  • [9] Atorvastatin, Valsartan, and N-Acetylcysteine Prevent Cardiac Hypertrophy and Overexpression of Myocardin in Pressure-Overloaded Rat Heart
    Chiu, Chiung-Zuan
    Wang, Bao-Wei
    Shyu, Kou-Gi
    ACTA CARDIOLOGICA SINICA, 2012, 28 (04) : 286 - 296
  • [10] Characterization of an animal model of postmenopausal cardiac hypertrophy and novel mechanisms responsible for cardiac decompensation using ovariectomized pressure-overloaded rats
    Bhuiyan, Md. Shenuarin
    Fukunaga, Kohji
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (01): : 213 - 221
12345